Roche (VTX:ROG)

Discover Roche, the Swiss pharmaceutical giant, world leader in cancer treatment and virology, with flagship products such as Valium and Tamiflu. The group offers an attractive yield of 3.24% and a sustained growth of its dividends, making it an interesting investment despite a higher volatility than its competitors.

Roche (VTX:ROG) Read More »

Abbott (NYSE:ABT)

Abbott Laboratories, an American pharmaceutical company founded in Chicago, is distinguished by its diversified range of health products including drugs, nutritional products and medical devices. With a solid product pipeline, remarkable financial stability and consistent dividend growth for several years, Abbott is positioned as an attractive long-term investment.

Abbott (NYSE:ABT) Read More »

Buy at the sound of the cannon

Financial markets often go through periods of purge through wars and catastrophes, as evidenced by the post-World War II eras and recent events. In this volatile environment, the investment strategy focused on growing dividends offers an interesting perspective to achieve financial independence, especially with the addition of solid stocks like General Dynamics to the portfolio.

Buy at the sound of the cannon Read More »

Nuclear: the hypocrisy of the Swiss government

In a context of panic around Swiss nuclear power plants, the decision to freeze the authorization procedures raises questions about the real seismic threat, particularly in Valais. While the plants are located in low-risk regions, the concern could be better placed on the dams which, in the event of a major earthquake, would pose a much greater danger.

Nuclear: the hypocrisy of the Swiss government Read More »